Passage Bio Company Top Insiders

PASG Stock  USD 5.56  0.21  3.64%   
Roughly 85 percent of Passage Bio's insiders are selling. The analysis of the overall insider sentiment regarding Passage Bio suggests that a large number of insiders are terrified. Passage Bio employs about 60 people. The company is managed by 13 executives with a total tenure of roughly 140 years, averaging almost 10.0 years of service per executive, having 4.62 employees per reported executive.

Insider Sentiment 15

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-06-26Orbimed Advisors LlcDisposed 10662 @ 6.6View
2025-06-25Orbimed Advisors LlcDisposed 6940 @ 6.6View
2025-06-24Orbimed Advisors LlcDisposed 11580 @ 7View
2025-04-24Orbimed Advisors LlcDisposed 3409 @ 6.4View
2025-04-22Orbimed Advisors LlcDisposed 3902 @ 6.8View
2025-04-17Orbimed Advisors LlcDisposed 3854 @ 6.6View
2025-04-15Orbimed Advisors LlcDisposed 516 @ 7.6View
2025-01-13Orbimed Advisors LlcDisposed 899 @ 12.8View
2025-01-10Orbimed Advisors LlcDisposed 6310 @ 13.2View
2025-01-08Orbimed Advisors LlcDisposed 3750 @ 13.6View
2025-01-06Orbimed Advisors LlcDisposed 974 @ 15.4View
2024-12-27Lynx1 Capital Management LpAcquired 18682 @ 13View
2024-12-20Orbimed Advisors LlcDisposed 11516 @ 12View
2024-12-11Orbimed Advisors LlcDisposed 4 @ 16View
2024-12-09Orbimed Advisors LlcDisposed 2709 @ 16.8View
2024-12-06Orbimed Advisors LlcDisposed 1045 @ 16.4View
2024-12-04Orbimed Advisors LlcDisposed 3810 @ 15.8View
2024-11-27Lynx1 Capital Management LpAcquired 1465 @ 13.4View
2024-11-25Lynx1 Capital Management LpAcquired 12999 @ 11.2View
2024-09-18Orbimed Advisors LlcDisposed 1281 @ 14.6View
Monitoring Passage Bio's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Passage Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.

Passage Bio's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Passage Bio's future performance. Based on our forecasts, it is anticipated that Passage will maintain a workforce of roughly 70 employees by August 2025.
 
Covid

Passage Bio Management Team Effectiveness

The company has return on total asset (ROA) of (0.3363) % which means that it has lost $0.3363 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8373) %, meaning that it created substantial loss on money invested by shareholders. Passage Bio's management efficiency ratios could be used to measure how well Passage Bio manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.66. The current Return On Capital Employed is estimated to decrease to -0.89. At this time, Passage Bio's Non Current Assets Total are most likely to increase significantly in the upcoming years. The Passage Bio's current Total Current Assets is estimated to increase to about 141.2 M, while Total Assets are projected to decrease to roughly 97.3 M.
The current Common Stock Shares Outstanding is estimated to decrease to about 53.2 M. The current Net Loss is estimated to decrease to about (128.6 M)

Passage Bio Workforce Comparison

Passage Bio is regarded fourth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,019. Passage Bio holds roughly 60.0 in number of employees claiming about 6% of equities under Health Care industry.

Passage Bio Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Passage Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Passage Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Passage Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-06-01
0.7778
7
9
 1,354,931 
 968,283 
2025-03-01
0.5
4
8
 1,344,305 
 381,426 
2024-12-01
0.6667
4
6
 829,998 
 389,700 
2024-09-01
0.5
2
4
 224,139 
 239,431 
2024-03-01
0.8571
6
7
 1,217,000 
 54,406 
2023-12-01
1.0
3
3
 130,000 
 130,000 
2023-09-01
0.5
3
6
 99,250 
 204,570 
2023-06-01
2.75
11
4
 1,376,894 
 24,855 
2022-12-01
2.0
6
3
 1,097,500 
 21,220 
2022-09-01
1.0
2
2
 53,000 
 6,681 
2021-12-01
0.5
1
2
 71,975 
 71,975 
2021-06-01
5.5
11
2
 194,057 
 30,829 
2021-03-01
3.0
12
4
 1,233,131 
 21,300 
2020-03-01
1.3243
49
37
 29,510,722 
 38,327,288 

Passage Bio Notable Stakeholders

A Passage Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Passage Bio often face trade-offs trying to please all of them. Passage Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Passage Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
William MDCEO PresidentProfile
Sue BrowneSenior DevelopmentProfile
Simona KingCFO SecProfile
JD EsqGeneral SecretaryProfile
Gregory FuestVice MarketingProfile
MSc MBAChief OfficerProfile
Kathleen BorthwickPrincipal FinanceProfile
Stuart HendersonSenior RelationsProfile
Eden FucciSenior OperationsProfile
Karl WhitneySenior AffairsProfile
Mark MDChief OfficerProfile
David MDVP DevelProfile
Desiree DDSVP AffairsProfile

About Passage Bio Management Performance

The success or failure of an entity such as Passage Bio often depends on how effective the management is. Passage Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Passage management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Passage management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.63)(0.66)
Return On Capital Employed(0.85)(0.89)
Return On Assets(0.63)(0.66)
Return On Equity(1.06)(1.00)

Passage Bio Workforce Analysis

Traditionally, organizations such as Passage Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Passage Bio within its industry.

Passage Bio Manpower Efficiency

Return on Passage Bio Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.1M
Net Loss Per Executive5M
Working Capital Per Employee990.9K
Working Capital Per Executive4.6M

Complementary Tools for Passage Stock analysis

When running Passage Bio's price analysis, check to measure Passage Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Passage Bio is operating at the current time. Most of Passage Bio's value examination focuses on studying past and present price action to predict the probability of Passage Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Passage Bio's price. Additionally, you may evaluate how the addition of Passage Bio to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
CEOs Directory
Screen CEOs from public companies around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal